UniProt ID | MAPK2_HUMAN | |
---|---|---|
UniProt AC | P49137 | |
Protein Name | MAP kinase-activated protein kinase 2 | |
Gene Name | MAPKAPK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 400 | |
Subcellular Localization | Cytoplasm . Nucleus . Phosphorylation and subsequent activation releases the autoinhibitory helix, resulting in the export from the nucleus into the cytoplasm. | |
Protein Description | Stress-activated serine/threonine-protein kinase involved in cytokine production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, CEP131, ELAVL1, HNRNPA0, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Phosphorylates HSF1; leading to the interaction with HSP90 proteins and inhibiting HSF1 homotrimerization, DNA-binding and transactivation activities. [PubMed: 16278218 Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to the dissociation of HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impairment of their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to the regulation of the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity, leading to inhibition of dependent degradation of ARE-containing transcripts. Phosphorylates CEP131 in response to cellular stress induced by ultraviolet irradiation which promotes binding of CEP131 to 14-3-3 proteins and inhibits formation of novel centriolar satellites] | |
Protein Sequence | MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MLSNSQGQSP -----CCCCCCCCCC | 32.89 | 28348404 | |
5 | Phosphorylation | ---MLSNSQGQSPPV ---CCCCCCCCCCCC | 32.10 | 28348404 | |
9 | Phosphorylation | LSNSQGQSPPVPFPA CCCCCCCCCCCCCCC | 37.69 | 22817900 | |
25 | Phosphorylation | APPPQPPTPALPHPP CCCCCCCCCCCCCCC | 28.07 | 22817900 | |
56 | Ubiquitination | KSGLQIKKNAIIDDY CCCCEEECCEEECCC | 53.92 | 29967540 | |
63 | Phosphorylation | KNAIIDDYKVTSQVL CCEEECCCCHHHHHC | 12.01 | 22817900 | |
64 | Acetylation | NAIIDDYKVTSQVLG CEEECCCCHHHHHCC | 46.13 | 23236377 | |
66 | Phosphorylation | IIDDYKVTSQVLGLG EECCCCHHHHHCCCC | 14.86 | - | |
67 | Phosphorylation | IDDYKVTSQVLGLGI ECCCCHHHHHCCCCC | 22.68 | 27251275 | |
84 | Acetylation | KVLQIFNKRTQEKFA EEEEHHCHHHHHHHH | 46.18 | 25953088 | |
84 | Ubiquitination | KVLQIFNKRTQEKFA EEEEHHCHHHHHHHH | 46.18 | 29967540 | |
93 | Ubiquitination | TQEKFALKMLQDCPK HHHHHHHHHHHHCHH | 33.85 | 29967540 | |
98 | S-palmitoylation | ALKMLQDCPKARREV HHHHHHHCHHHHHHH | 2.10 | 29575903 | |
100 | Ubiquitination | KMLQDCPKARREVEL HHHHHCHHHHHHHHH | 61.94 | - | |
159 | Phosphorylation | DRGDQAFTEREASEI HCCCHHCCHHHHHHH | 36.83 | 26546556 | |
188 | Ubiquitination | NIAHRDVKPENLLYT CCCCCCCCHHHCEEC | 51.40 | - | |
204 | Ubiquitination | KRPNAILKLTDFGFA CCCCEEEEECCCCCC | 43.13 | 29967540 | |
206 | Phosphorylation | PNAILKLTDFGFAKE CCEEEEECCCCCCCC | 27.91 | 7592979 | |
212 | Ubiquitination | LTDFGFAKETTSHNS ECCCCCCCCCCCCCC | 54.02 | 29967540 | |
214 | Ubiquitination | DFGFAKETTSHNSLT CCCCCCCCCCCCCCC | 32.65 | 24816145 | |
214 | Phosphorylation | DFGFAKETTSHNSLT CCCCCCCCCCCCCCC | 32.65 | 21945579 | |
215 | Phosphorylation | FGFAKETTSHNSLTT CCCCCCCCCCCCCCC | 29.13 | 21945579 | |
216 | Phosphorylation | GFAKETTSHNSLTTP CCCCCCCCCCCCCCC | 28.26 | 21945579 | |
219 | Phosphorylation | KETTSHNSLTTPCYT CCCCCCCCCCCCCCC | 22.97 | 21945579 | |
221 | Phosphorylation | TTSHNSLTTPCYTPY CCCCCCCCCCCCCCC | 28.63 | 21945579 | |
222 | Phosphorylation | TSHNSLTTPCYTPYY CCCCCCCCCCCCCCE | 19.36 | 23401153 | |
222 | O-linked_Glycosylation | TSHNSLTTPCYTPYY CCCCCCCCCCCCCCE | 19.36 | OGP | |
225 | Phosphorylation | NSLTTPCYTPYYVAP CCCCCCCCCCCEECH | 16.38 | 21945579 | |
226 | Phosphorylation | SLTTPCYTPYYVAPE CCCCCCCCCCEECHH | 16.13 | 21945579 | |
228 | Phosphorylation | TTPCYTPYYVAPEVL CCCCCCCCEECHHHH | 11.63 | 21945579 | |
229 | Phosphorylation | TPCYTPYYVAPEVLG CCCCCCCEECHHHHC | 7.43 | 21945579 | |
240 | Phosphorylation | EVLGPEKYDKSCDMW HHHCCHHCCCCCCHH | 27.26 | 23312004 | |
272 | Phosphorylation | SNHGLAISPGMKTRI CCCCCEECCCCCCEE | 15.14 | 22817900 | |
307 | Ubiquitination | MLIRNLLKTEPTQRM HHHHHHHCCCCCCCC | 54.75 | 24816145 | |
311 | Phosphorylation | NLLKTEPTQRMTITE HHHCCCCCCCCCHHH | 23.68 | 24532841 | |
317 | Phosphorylation | PTQRMTITEFMNHPW CCCCCCHHHHHCCCH | 17.63 | 22322096 | |
328 | Phosphorylation | NHPWIMQSTKVPQTP CCCHHHCCCCCCCCC | 16.89 | 19060867 | |
329 | Phosphorylation | HPWIMQSTKVPQTPL CCHHHCCCCCCCCCC | 21.12 | 22322096 | |
334 | Phosphorylation | QSTKVPQTPLHTSRV CCCCCCCCCCCHHHH | 23.03 | 22322096 | |
338 | Phosphorylation | VPQTPLHTSRVLKED CCCCCCCHHHHHHHH | 26.38 | 22322096 | |
339 | Phosphorylation | PQTPLHTSRVLKEDK CCCCCCHHHHHHHHH | 15.05 | 26552605 | |
353 | Ubiquitination | KERWEDVKEEMTSAL HHHHHHHHHHHHHHH | 61.35 | 29967540 | |
353 | Sumoylation | KERWEDVKEEMTSAL HHHHHHHHHHHHHHH | 61.35 | 21131586 | |
353 | Sumoylation | KERWEDVKEEMTSAL HHHHHHHHHHHHHHH | 61.35 | - | |
358 | Phosphorylation | DVKEEMTSALATMRV HHHHHHHHHHHHCCC | 21.70 | 28555341 | |
367 | Phosphorylation | LATMRVDYEQIKIKK HHHCCCCHHHHEEEE | 13.58 | 28796482 | |
371 | Ubiquitination | RVDYEQIKIKKIEDA CCCHHHHEEEEHHHC | 48.44 | 29967540 | |
374 | Ubiquitination | YEQIKIKKIEDASNP HHHHEEEEHHHCCCH | 55.59 | 29967540 | |
385 | Ubiquitination | ASNPLLLKRRKKARA CCCHHHHHHHHHHHH | 50.56 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
9 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
25 | T | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
25 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
25 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
25 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
25 | T | Phosphorylation | Kinase | GRK1 | Q15835 | GPS |
222 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
222 | T | Phosphorylation | Kinase | MK14 | Q16539 | PhosphoELM |
222 | T | Phosphorylation | Kinase | GRK1 | Q15835 | GPS |
222 | T | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
222 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
272 | S | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
272 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
272 | S | Phosphorylation | Kinase | MK14 | Q16539 | PhosphoELM |
272 | S | Phosphorylation | Kinase | GRK1 | Q15835 | GPS |
272 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
334 | T | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
334 | T | Phosphorylation | Kinase | MK14 | Q16539 | PhosphoELM |
334 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
334 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
334 | T | Phosphorylation | Kinase | GRK1 | Q15835 | GPS |
338 | T | Phosphorylation | Kinase | MAPK2 | P49137 | PhosphoELM |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAPK2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Identification of novel phosphorylation sites required for activationof MAPKAP kinase-2."; Ben-Levy R., Leighton I.A., Doza Y.N., Attwood P., Morrice N.,Marshall C.J., Cohen P.; EMBO J. 14:5920-5930(1995). Cited for: PHOSPHORYLATION AT SER-9; THR-25; THR-222; SER-272 AND THR-334, ANDMUTAGENESIS OF ASP-207; THR-222; SER-272 AND THR-334. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-63, AND MASSSPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"MK2 SUMOylation regulates actin filament remodeling and subsequentmigration in endothelial cells by inhibiting MK2 kinase and HSP27phosphorylation."; Chang E., Heo K.S., Woo C.H., Lee H., Le N.T., Thomas T.N.,Fujiwara K., Abe J.; Blood 117:2527-2537(2011). Cited for: SUMOYLATION AT LYS-353, AND MUTAGENESIS OF LYS-353. |